Healthcare Finance News January 7, 2019
U.S. healthcare venture fundraising reached $9.6 billion, marking four straight years of healthy activity.
Healthcare venture investment in the U.S. and Europe reached a new high in 2018, according to Silicon Valley Bank’s annual analysis. Investment totals in 2018 grew more than 50 percent over 2017, with the activity due in large part to record Series A investments in U.S. biopharma companies.
U.S. healthcare venture fundraising reached $9.6 billion, marking the fourth consecutive year of robust activity. On the exits side, global biopharma IPO and mergers and acquisitions total deal value reached $49 billion, also a record.
“This big appetite for healthcare venture investments, especially among generalist and crossover investors, is the result of remarkable science and technology advancements leading...